News

The UAB O'Neal Cancer Center's Office of Community Outreach and Engagement is proud to announce the 2026 Community Dissemination Institute (CDI).

Rebecca Arend, M.D., MPH, Associate Director of Clinical Research at the UAB O'Neal Cancer Center, was appointed as Gynecologic Oncology Vice Chair of the NRG Oncology Translational Science Committee.

UAB O’Neal Cancer Center investigators have access to a network of resources designed to strengthen NIH R01 grant applications.

The O'Neal Cancer Center awarded Aurelio Galli, Ph.D., D.Sc., and Angela Carter, Ph.D., $10,000 to advance glioblastoma research as part of the O'Neal Invests program.

The O'Neal Cancer Center held its 2026 Iron Strong Awards, which recognizes cancer patients who went through a clinical trial.

Rebecca Hall was diagnosed with leptomeningeal metastasis and was weeks from passing, until she enrolled as the first patient in a clinical trial.

Barry Sleckman, M.D., Ph.D., UAB O’Neal Cancer Center Director, recently joined the One Voice Against Cancer (OVAC) congressional briefing.

Barry Sleckman, M.D., Ph.D., UAB O’Neal Cancer Center Director, recently joined the One Voice Against Cancer (OVAC) congressional briefing.

The UAB O'Neal Cancer Center's Gynecologic Oncology Program and Infirmary Health's partnership is a meaningful expansion of women’s cancer care services.

The UAB O’Neal Cancer Center is playing a prominent role at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden.

Faculty, physicians, scientists, and trainees from the UAB O’Neal Cancer Center joined oncology leaders from around the world at the 2026 (ASCO) Annual Meeting.

Faculty and researchers from the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB) will join oncology professionals from around the world at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2 in Chicago.

UAB's partnership with Infirmary Health offers patients around the southeast aceess to UAB-trained physicians, clinical trials, and all of the resources of the UAB O'Neal Cancer Center.

Andrea Comba, Ph.D., recently secured the V Foundation’s V Scholar Award through the support of her colleagues at the O’Neal Cancer Center.

The UAB O’Neal Cancer Center is pleased to announce the latest recipients of the O’Neal NextGen Scholar Awards. This year, two of these awards were generously funded by the Breast Cancer Research Foundation of Alabama (BCRFA).

The UAB O’Neal Cancer Center is pleased to announce the latest recipients of the O’Neal NextGen Scholar Awards. These awards are funded by the Young Supporters Board (YSB) of the O’Neal Cancer Center.

The UAB O’Neal Cancer Center is pleased to announce the latest O’Neal Invests grant awards. In this cycle, three grants received the award, including two funded by the BCRFA and by the Children’s of Alabama Hope Fund, respectively.

The O'Neal Cancer Center recently reached a major milestone as more than 500 patients now are being treated with CAR T therapy. This achievement underscores the center’s leadership in advancing innovative treatments and in broadening access to lifesaving care for patients across Alabama and beyond.

A multidisciplinary team at UAB successfully performed Alabama’s first deceased-donor bone marrow transplant.

To improve service and better meet demand, the UAB O’Neal Cancer Center began expanding our Acton Road clinic in March. The project should be completed by fall 2026.

Jorge Cortes, M.D. will join the Division of Hematology and Oncology as Chief of Hematology; furthermore, Cortes will serve as the Deputy Director of the O'Neal Cancer Center. Similarly, Mehmet Akce, M.D., will serve as Interim Chief of Oncology.

The University of Alabama System Board of Trustees has appointed Anindya Dutta, MBBS, Ph.D., as the next holder of the O’Neal-Sokol Breast Cancer Research Foundation of Alabama (BCRFA) Endowed Chair.

Nature Cancer magazine published a study led by Dr. Stringer-Reasor that highlights a promising advance in the treatment of one of the most challenging complications of breast cancer, leptomeningeal metastasis.

Clinical trials enhance healthcare by offering patients access to the newest and most promising experimental treatments. In this article, Jane Longshore writes about the clinical trial work going on at UAB and at the UAB O'Neal Cancer Center.